The Economic Burden of Vision Loss and Blindness in the United States - PubMed (original) (raw)
. 2022 Apr;129(4):369-378.
doi: 10.1016/j.ophtha.2021.09.010. Epub 2021 Sep 21.
Affiliations
- PMID: 34560128
- DOI: 10.1016/j.ophtha.2021.09.010
The Economic Burden of Vision Loss and Blindness in the United States
David B Rein et al. Ophthalmology. 2022 Apr.
Abstract
Purpose: To estimate the economic burden of vision loss (VL) in the United States and by state.
Design: Analysis of secondary data sources (American Community Survey [ACS], American Time Use Survey, Bureau of Labor Statistics, Medical Expenditure Panel Survey [MEPS], National and State Health Expenditure Accounts, and National Health Interview Survey [NHIS]) using attributable fraction, regression, and other methods to estimate the incremental direct and indirect 2017 costs of VL.
Participants: People with a yes response to a question asking if they are blind or have serious difficulty seeing even when wearing glasses in the ACS, MEPS, or NHIS.
Main outcome measures: We estimated the direct costs of medical, nursing home (NH), and supportive services and the indirect costs of absenteeism, lost household production, reduced labor force participation, and informal care by age group, sex, and state in aggregate and per person with VL.
Results: We estimated an economic burden of VL of 134.2billion:134.2 billion: 134.2billion:98.7 billion in direct costs and 35.5billioninindirectcosts.ThelargestburdencomponentswereNH(35.5 billion in indirect costs. The largest burden components were NH (35.5billioninindirectcosts.ThelargestburdencomponentswereNH(41.8 billion), other medical care services ($30.9 billion), and reduced labor force participation ($16.2 billion), all of which accounted for 66% of the total. Those with VL incurred 16838peryearinincrementalburden.Informalcarewasthelargestburdencomponentforpeople0to18yearsofage,reducedlaborforceparticipationwasthelargestburdencomponentforpeople19to64yearsofage,andNHcostswerethelargestburdencomponentforpeople65yearsofageorolder.NewYork,Connecticut,Massachusetts,RhodeIsland,andVermontexperiencedthehighestcostsperpersonwithVL.Sensitivityanalysesindicatetotalburdenmayrangebetween16 838 per year in incremental burden. Informal care was the largest burden component for people 0 to 18 years of age, reduced labor force participation was the largest burden component for people 19 to 64 years of age, and NH costs were the largest burden component for people 65 years of age or older. New York, Connecticut, Massachusetts, Rhode Island, and Vermont experienced the highest costs per person with VL. Sensitivity analyses indicate total burden may range between 16838peryearinincrementalburden.Informalcarewasthelargestburdencomponentforpeople0to18yearsofage,reducedlaborforceparticipationwasthelargestburdencomponentforpeople19to64yearsofage,andNHcostswerethelargestburdencomponentforpeople65yearsofageorolder.NewYork,Connecticut,Massachusetts,RhodeIsland,andVermontexperiencedthehighestcostsperpersonwithVL.Sensitivityanalysesindicatetotalburdenmayrangebetween76 and $218 billion depending on the assumptions used in the model.
Conclusions: Self-reported VL imposes a substantial economic burden on the United States. Burden accrues in different ways at different ages, leading to state differences in the composition of per-person costs based on the age composition of the population with VL. Information on state variation can help local decision makers target resources better to address the burden of VL.
Keywords: Absenteeism; Blindness; Burden of disease; Cost of illness; Direct medical costs; Economic burden; Labor force participation; Nursing home costs; Productivity losses; Vision loss.
Copyright © 2021 American Academy of Ophthalmology. All rights reserved.
Similar articles
- The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
Wittenborn JS, Zhang X, Feagan CW, Crouse WL, Shrestha S, Kemper AR, Hoerger TJ, Saaddine JB; Vision Cost-Effectiveness Study Group. Wittenborn JS, et al. Ophthalmology. 2013 Sep;120(9):1728-35. doi: 10.1016/j.ophtha.2013.01.068. Epub 2013 Apr 28. Ophthalmology. 2013. PMID: 23631946 Free PMC article. - The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
Bebo B, Cintina I, LaRocca N, Ritter L, Talente B, Hartung D, Ngorsuraches S, Wallin M, Yang G. Bebo B, et al. Neurology. 2022 May 3;98(18):e1810-e1817. doi: 10.1212/WNL.0000000000200150. Epub 2022 Apr 13. Neurology. 2022. PMID: 35418457 Free PMC article. - Economic costs of diabetes in the US in 2002.
Hogan P, Dall T, Nikolov P; American Diabetes Association. Hogan P, et al. Diabetes Care. 2003 Mar;26(3):917-32. doi: 10.2337/diacare.26.3.917. Diabetes Care. 2003. PMID: 12610059 - Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review. - Economic Costs of Diabetes in the U.S. in 2022.
Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, ElSayed NA, Bannuru RR. Parker ED, et al. Diabetes Care. 2024 Jan 1;47(1):26-43. doi: 10.2337/dci23-0085. Diabetes Care. 2024. PMID: 37909353 Review.
Cited by
- Trend and projection of the prevalence and burden of near vision loss in China and globally from 1990 to 2030: A Bayesian age-period-cohort modeling study.
Xu Y, Mao Y, Lin X, Gao Z, Ruan X. Xu Y, et al. J Glob Health. 2024 Aug 2;14:04119. doi: 10.7189/jogh.14.04119. J Glob Health. 2024. PMID: 39091200 Free PMC article. - Impact of Social Vulnerability Index on the Development of Severe Visual Impairment or Blindness From Glaucoma.
Swaminathan SS, Medeiros FA, Gedde SJ. Swaminathan SS, et al. Am J Ophthalmol. 2024 Nov;267:172-181. doi: 10.1016/j.ajo.2024.06.024. Epub 2024 Jul 4. Am J Ophthalmol. 2024. PMID: 38971319 - Vision Need Profiles for the City of Richmond, Virginia: A Pilot Application of Calibration Methods to Vision Surveillance.
Rein DB, Herring-Nathan ER. Rein DB, et al. Ophthalmol Sci. 2023 Nov 14;4(2):100429. doi: 10.1016/j.xops.2023.100429. eCollection 2024 Mar-Apr. Ophthalmol Sci. 2023. PMID: 38187127 Free PMC article. - Estimation of the lost productivity to the GDP and the national cost of correcting visual impairment from refractive error in Kenya.
Muma S, Naidoo KS, Hansraj R. Muma S, et al. PLoS One. 2024 Mar 25;19(3):e0300799. doi: 10.1371/journal.pone.0300799. eCollection 2024. PLoS One. 2024. PMID: 38527046 Free PMC article. - Vitamin K and the Visual System-A Narrative Review.
Mong MA. Mong MA. Nutrients. 2023 Apr 18;15(8):1948. doi: 10.3390/nu15081948. Nutrients. 2023. PMID: 37111170 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources